© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Cogstate Limited (COGZF) stock remained unchanged at $1.82 a share on OTC. The stock opened at $1.70, fluctuating between $1.70 to $1.82 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 28, 2026 | 1.85 | 1.85 | 1.82 | 1.82 | 6K |
| May 22, 2026 | 1.70 | 1.86 | 1.70 | 1.86 | 5.27K |
| May 08, 2026 | 1.69 | 1.69 | 1.69 | 1.69 | 3.77K |
| Apr 29, 2026 | 1.76 | 1.76 | 1.76 | 1.76 | 470 |
| Apr 27, 2026 | 1.70 | 1.70 | 1.70 | 1.70 | 500 |
| Apr 22, 2026 | 1.76 | 1.76 | 1.76 | 1.76 | 1.63K |
| Apr 16, 2026 | 1.57 | 1.82 | 1.57 | 1.82 | 4.47K |
| Apr 14, 2026 | 1.51 | 1.51 | 1.51 | 1.51 | 207 |
| Apr 08, 2026 | 1.55 | 1.55 | 1.55 | 1.55 | 59.07K |
| Mar 27, 2026 | 1.50 | 1.50 | 1.50 | 1.50 | 3.4K |
| Mar 20, 2026 | 1.53 | 1.53 | 1.53 | 1.53 | 595 |
| Mar 03, 2026 | 1.50 | 1.50 | 1.50 | 1.50 | 4K |
| Mar 02, 2026 | 1.64 | 1.64 | 1.64 | 1.64 | 600 |
| Feb 26, 2026 | 1.49 | 1.49 | 1.49 | 1.49 | 6.77K |
| Feb 06, 2026 | 1.51 | 1.51 | 1.51 | 1.51 | 1K |
| Jan 29, 2026 | 1.26 | 1.45 | 1.26 | 1.45 | 4.77K |
| Jan 27, 2026 | 1.36 | 1.36 | 1.36 | 1.36 | 568 |
| Jan 16, 2026 | 1.58 | 1.70 | 1.58 | 1.70 | 900 |
| Jan 14, 2026 | 1.60 | 1.60 | 1.60 | 1.60 | 300 |
| Jan 12, 2026 | 1.55 | 1.55 | 1.55 | 1.55 | 100 |
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
| Employees | 147 |
| Beta | -0.02 |
| Sales or Revenue | $50.81M |
| 5Y Sales Change% | 0.392% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |